Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells

The prognosis of gioblastoma, the standard chemotherapy agent for which is temozolomide (TMZ), remains poor despite recent advances in multimodal treatments. Therefore, it is necessary to identify and develop novel therapeutics for this malignant disease. Ribavirin, an anti-viral agent which is one...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Ochiai, Yushi, Sumi, Koichiro, Sano, Emiko, Yoshimura, Sodai, Yamamuro, Shun, Ogino, Akiyoshi, Ueda, Takuya, Suzuki, Yutaka, Nakayama, Tomohiro, Hara, Hiroyuki, Katayama, Yoichi, Yoshino, Atsuo
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475644/
https://ncbi.nlm.nih.gov/pubmed/32934745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12039
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados